Natural medicine delivery from 3D printed bone substitutes
Journal of Controlled Release · 2024-01 · 365 · 848-875
DOI: 10.1016/j.jconrel.2023.09.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-01. Verfasst von Susmita Bose und 2 weiteren Autor:innen. Beteiligte Einrichtung: W. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, …. Hauptthemen laut MEDLINE: Bone Substitutes. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Unmet medical needs in treating critical-size bone defects have led to the development of numerous innovative bone tissue engineering implants. Although additive manufacturing allows flexible patient-specific treatments by modifying topological properties with various materials, the development of ideal bone implants that aid new tissue regeneration and reduce post-implantation bone disorders has been limited. Natural biomolecules are gaining the attention of the health industry due to their excellent safety profiles, providing equivalent or superior performances when compared to more expensive growth factors and synthetic drugs. Supplementing additive manufacturing with natural biomolecules enables the design of novel multifunctional bone implants that provide controlled biochemical delivery for bone tissue engineering applications. Controlled release of naturally derived biomolecules from a three-dimensional (3D) printed implant may improve implant-host tissue integration, new bone formation, bone healing, and blood vessel growth. The present review introduces us to the current progress and limitations of 3D printed bone implants with drug delivery capabilities, followed by an in-depth discussion on cutting-edge technologies for incorporating natural medicinal compounds embedded within the 3D printed scaffolds or on implant surfaces, highlighting their applications in several pre- and post-implantation bone-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- W. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, United States. Electronic address: sbose@wsu.edu.
- W. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, United States.
Förderung
- NIDCR NIH HHS
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
Zitieren
APA
Bose, S., Sarkar, N., & Jo, Y. (2024). Natural medicine delivery from 3D printed bone substitutes. Journal of Controlled Release, 365, 848-875. https://doi.org/10.1016/j.jconrel.2023.09.025
Vancouver
Bose S, Sarkar N, Jo Y. Natural medicine delivery from 3D printed bone substitutes. Journal of Controlled Release. 2024;365:848-875. doi:10.1016/j.jconrel.2023.09.025
BibTeX
@article{Bose2024,
author = {Bose, Susmita and Sarkar, Naboneeta and Jo, Yongdeok},
title = {Natural medicine delivery from 3D printed bone substitutes},
journal = {Journal of Controlled Release},
year = {2024},
volume = {365},
pages = {848--875},
doi = {10.1016/j.jconrel.2023.09.025}
}
EUVIMED